- Joined
- Oct 14, 2015
- Messages
- 64,268
- Reaction score
- 62,677
- Location
- Massachusetts
- Gender
- Male
- Political Leaning
- Other
Hydroxychloroquine did not prevent healthy people exposed to covid-19 from getting the disease caused by the coronavirus, according to a study being published Wednesday in the New England Journal of Medicine. The study is the first randomized clinical trial that tested the antimalarial drug, touted by President Trump, as a preventive measure. It showed that hydroxychloroquine was no more effective than a placebo — in this case, a vitamin — in protecting people exposed to covid-19. “As we say in Tennessee, ‘That dog won’t hunt’ — it didn’t work,” said William Schaffner, professor of preventive medicine and infectious diseases at Vanderbilt University Medical Center. Schaffner, who was not involved in the trial, praised it as “rigorously done.”
The results were the latest development on a highly charged medical and political issue — the efficacy of hydroxychloroquine in combating covid-19. President Trump has repeatedly touted the drug as a “game changer” for covid-19, and recently said he took it for several days. But federal regulators have said it should be used only for hospitalized patients or in clinical trials because of possible side effects, including serious heart-rhythm issues.Researchers at the University of Minnesota Medical School launched the trial in mid-March. They enrolled more than 800 adults in the United States and Canada who were exposed to someone with covid-19 because of their jobs as health care workers or first responders, or because they lived with someone with the disease. The study was a randomized placebo-controlled trial, and was double-blinded, meaning neither the participants nor the researchers knew what the participants received. Such a study is considered the gold standard for clinical trials.
[cont].
https://www.washingtonpost.com/health/2020/06/03/hydroxychloroquine-clinical-trial-results/
Yet more evidence that whether or not it is harmful, or how harmful, it is no preventative.
The results were the latest development on a highly charged medical and political issue — the efficacy of hydroxychloroquine in combating covid-19. President Trump has repeatedly touted the drug as a “game changer” for covid-19, and recently said he took it for several days. But federal regulators have said it should be used only for hospitalized patients or in clinical trials because of possible side effects, including serious heart-rhythm issues.Researchers at the University of Minnesota Medical School launched the trial in mid-March. They enrolled more than 800 adults in the United States and Canada who were exposed to someone with covid-19 because of their jobs as health care workers or first responders, or because they lived with someone with the disease. The study was a randomized placebo-controlled trial, and was double-blinded, meaning neither the participants nor the researchers knew what the participants received. Such a study is considered the gold standard for clinical trials.
[cont].
https://www.washingtonpost.com/health/2020/06/03/hydroxychloroquine-clinical-trial-results/
Yet more evidence that whether or not it is harmful, or how harmful, it is no preventative.